Search research articles
Contact Us
Filters
Showing results (11-20 of 121) with videos related to
Page
of 13
Sort By:
British Journal of Clinical Pharmacology
|
May 25, 2012
Prescribing and partnership with patients
Christine Bond, Alison Blenkinsopp, David K Raynor
International Journal of Clinical Pharmacy
|
July 2, 2014
Design and comprehensibility of over-the-counter product labels and leaflets: a narrative review
Vivien Tong, David K Raynor, Parisa Aslani
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
Comparative User Testing of Australian and UK Over-the-Counter Labels and Leaflets for Diclofenac
Vivien Tong, David K Raynor, Parisa Aslani
Journal of Neurochemistry
|
October 1, 1992
Analogues of somatostatin bind selectively to brain somatostatin receptor subtypes
K Raynor, D C Coy, T Reisine
Drug Safety
|
March 28, 2008
Adequacy of patient information on adverse effects: an assessment of patient information leaflets in the UK
Neil Carrigan, D K Raynor, Peter Knapp
Research in Social & Administrative Pharmacy : RSAP
|
May 27, 2017
Developing alternative over-the-counter medicine label formats: How do they compare when evaluated by consumers?
Vivien Tong, David K Raynor, Parisa Aslani
Research in Social & Administrative Pharmacy : RSAP
|
July 18, 2016
User testing as a method for identifying how consumers say they would act on information related to over-the-counter medicines
Vivien Tong, David K Raynor, Parisa Aslani
Patient Education and Counseling
|
May 23, 2001
Patient information leaflets for medicines: using consumer testing to determine the most effective design
D Dickinson, D K Raynor, M Duman
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
August 1, 2015
'It's all there in black and white' - or is it? Consumer perspectives on the proposed Australian Medicine Information Box over-the-counter label format
Vivien Tong, David K Raynor, Parisa Aslani
Lancet (London, England)
|
March 19, 2002
Provision of information about drug side-effects to patients
D C Berry, P Knapp, D K Raynor
Page
of 13
Search research articles
Search
Showing results (11-20 of 121) with videos related to
Sort By:
Page
of 13
British Journal of Clinical Pharmacology
|
May 25, 2012
Prescribing and partnership with patients
Christine Bond, Alison Blenkinsopp, David K Raynor
International Journal of Clinical Pharmacy
|
July 2, 2014
Design and comprehensibility of over-the-counter product labels and leaflets: a narrative review
Vivien Tong, David K Raynor, Parisa Aslani
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
Comparative User Testing of Australian and UK Over-the-Counter Labels and Leaflets for Diclofenac
Vivien Tong, David K Raynor, Parisa Aslani
Journal of Neurochemistry
|
October 1, 1992
Analogues of somatostatin bind selectively to brain somatostatin receptor subtypes
K Raynor, D C Coy, T Reisine
Drug Safety
|
March 28, 2008
Adequacy of patient information on adverse effects: an assessment of patient information leaflets in the UK
Neil Carrigan, D K Raynor, Peter Knapp
Research in Social & Administrative Pharmacy : RSAP
|
May 27, 2017
Developing alternative over-the-counter medicine label formats: How do they compare when evaluated by consumers?
Vivien Tong, David K Raynor, Parisa Aslani
Research in Social & Administrative Pharmacy : RSAP
|
July 18, 2016
User testing as a method for identifying how consumers say they would act on information related to over-the-counter medicines
Vivien Tong, David K Raynor, Parisa Aslani
Patient Education and Counseling
|
May 23, 2001
Patient information leaflets for medicines: using consumer testing to determine the most effective design
D Dickinson, D K Raynor, M Duman
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
August 1, 2015
'It's all there in black and white' - or is it? Consumer perspectives on the proposed Australian Medicine Information Box over-the-counter label format
Vivien Tong, David K Raynor, Parisa Aslani
Lancet (London, England)
|
March 19, 2002
Provision of information about drug side-effects to patients
D C Berry, P Knapp, D K Raynor
Page
of 13